Around 40% of all new cancer cases in Europe relate to various risk factors and could be prevented.
But what do we know about the effectiveness and cost-effectiveness of various prevention measures? How realistic is it to bring the figure down to 0%?
This and more was discussed by Thomas Hofmarcher (IHE) and Nikolai Pushkarev (European Public Health Alliance) in a webinar.
Watch the webinar here